14563; minerAlocorticoid-Receptor antagonist Tolerability Study) – A randomized, double-blind, multi-center phase IIa study to assess safety and tolerability of different oral doses of BAY 94-8862 in subjects with stable CHF with left ventricular systolic dysfunction and mild (Part A, 60 mL/min/1.73 m2 eGFR